Clinical trial
Prospective, Multi-Center Clinical Study of the Bard® COVERA™ Arteriovenous (AV) Stent Graft in the Treatment of Stenosis at the Graft-Vein Anastomosis of AV Graft Circuits (AVeVA)
NCT02790606 is registered in ClinicalTrials.gov with C. R. Bard as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Multi-Center Clinical Study of the Bard® COVERA™ Arteriovenous (AV) Stent Graft in the Treatment of Stenosis at the Graft-Vein Anastomosis of AV Graft Circuits (AVeVA)
- Lead sponsor
- C. R. Bard
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2016
- Completion date
- March 16, 2019
- Enrollment
- 110 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
restenosis, stenosis